Immune Correlates of Depression

  • Michael Irwin
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 461)


Substantial evidence has shown that major depression is associated with immune variations. In a meta-analytic review of over thirty-five independent study samples conducted through 1991, depression was found to be associated with reliable alterations in several enumerative measures and in functional assays such as mitogen induced lymphocyte proliferation and natural killer (NK) cell activity (Herbert & Cohen, 1993a). Since 1991, many additional studies on the relationship between depression and immune measures have been published which has led to a recent reevaluation of the immune findings in depression (Zorrilla, Luborsky, McKay, Rosenthal, Houldin, Tax, McCorkle, Seligman, & Schmidt, 1998). While both reviews observed similar relations between depression and several immune measures including major immune cell classes, lymphocyte proliferation, and NK activity, conflicting results were obtained for many other measures. An enormous heterogeneity in the findings is suggested by the discrepancies between these two large meta-analytic reviews.


Depressive Symptom Major Depression Depressed Patient Psychosomatic Medicine Lymphokine Activate Killer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Albrecht, J., Helderman, J., Schlesser, M., & Rush, J. (1985). A controlled study of cellular immune function in affective disorders before and during somatic therapy. Psychiatry Research, 15, 185–193.PubMedCrossRefGoogle Scholar
  2. Altshuler, L.L., Plaeger-Marshall, S., Richeimer, S., Daniels, M., & Baxter, L. R., Jr. (1989). Lymphocyte function in major depression. Acta Psychiatrica Scandinavica, 80, 132–136.PubMedCrossRefGoogle Scholar
  3. American Psychiatric Association. (1994). Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. Washington, D.C.: American Psychiatric Press.Google Scholar
  4. Andreoli, A., Keller, S. E., Rabaeus, M., Zaugg, L., Garrone, G., & Taban, C. (1992). Immunity, major depression, and panic disorder comorbidity. Biological Psychiatry, 31, 896–908.PubMedCrossRefGoogle Scholar
  5. Andreoli, A V., Keller, S. E., Rabaeus, M., Marin, P., Bartlett, J. A., & Taban, C. (1993). Depression and immunity: age, severity, and clinical course. Brain, Behavior & immunity, 7, 279–292.CrossRefGoogle Scholar
  6. Bartoloni, C., Guidi, L., Antico, L., Pili, R., Cursi, F., Carbonin, P., Gambassi, G., Rumi, G, Di Giovanni, A., Menichella, G., & et al. (1990). Psychological status of institutionalized aged: influences on immune parameters and endocrinological correlates. International Journal of Neuroscience, 51, 279–281.PubMedCrossRefGoogle Scholar
  7. Benca, R. M., Obermeyer, W. H., Thisted, R. A., & Gillin, J. C. (1992). Sleep and psychiatric disorders: a meta analysis. Archives of General Psychiatry, 49, 651–668.PubMedGoogle Scholar
  8. Birmaher, B., Rabin, B. S., Garcia, M. R., Jain, U., Whiteside, T. L., Williamson, D. E., al-Shabbout, M., Nelson, B. C., Dahl, R. E., & Ryan, N. D. (1994). Cellular immunity in depressed, conduct disorder, and normal adolescents: role of adverse life events. Journal of American Academy of Child and Adolescent Psychiatry, 33, 671–678.CrossRefGoogle Scholar
  9. Born, J., Lange, T., Hansen, K., Molle, M., & Fehm, H. L. (1997). Effects of sleep and circadian rhythm on human circulating immune cells. Journal of Immunology, 158, 4454–4464.Google Scholar
  10. Breslau, N., Peterson, E. L., Schultz, L. R., Chilcoat, H. D., & Andreski, P. (1998). Major depression and stages of smoking. A longitudinal investigation. Archives of General Psychiatry, 55, 161–166.PubMedCrossRefGoogle Scholar
  11. Brown, G. W. & Harris, T. (1978). Social Origins of Depression: A Study of Psychiatric Disorders in Women. New York: The Free Press.Google Scholar
  12. Brown, G. W., Harris, T. O., & Hepworth, C. (1994). Life events and endogenous depression. Archives of General Psychiatry, 51, 525–534.PubMedGoogle Scholar
  13. Cadoret, R. J. (1981). Depression and alcoholism. In R. E. Meyer, B. C. Glueck, & J. E. OBrien (Eds.), Evaluation of the alcoholic. Rockville, Md: Nat Institute on Alcohol Abuse and Alcoholism.Google Scholar
  14. Calabrese, J. R., Skwerer, R. G., Barna, B., Gulledge, A. D., Valenzuela, R., Butkus, A., Subichin, S., & Krupp, N. E. (1986). Depression, immunocompetence, and prostaglandins of the E series. Psychiatry Research, 17, 41–47.PubMedCrossRefGoogle Scholar
  15. Caldwell, C. L., Irwin, M., & Lohr, J. (1991). Reduced natural killer cell cytotoxicity in depression but not in schizophrenia. Biological Psychiatry, 30, 1131–1138.PubMedCrossRefGoogle Scholar
  16. Chiappelli, F. & Gottesfeld, Z. (1995). Introduction to the symposium on alcohol and T-cell immunity [comment]. Alcoholism: Clinical & Experimental Research, 19, 535–538.CrossRefGoogle Scholar
  17. Cleary, P. & Guy, W. (1977). Factor analysis of the Hamilton Depression Scale. Drugs Experimental Clinical Research, 1, 115–120.Google Scholar
  18. Cohen, S., Tyrrell, D. A., & Smith, A. P. (1991). Psychological stress and susceptibility to the common cold. New England Journal of Medicine, 325(9), 606–656.PubMedCrossRefGoogle Scholar
  19. Cohen, S., Doyle, W. J., Skoner, D. P., Rabin, B. S., & Gwaltney, J. M. (1997). Social ties and susceptibility to the common cold. Journal of the American Medical Association, 277, 1940–1944.PubMedCrossRefGoogle Scholar
  20. Cosyns, P., Maes, M., Vandewoude, M., Stevens, W. J., DeClerck, L. S., & Schotte, C. (1989). Impaired mitogen-induced lymphocyte responses and the hypothalamic-pituitary-adrenal axis in depressive disorders. Journal of Affective Disorders, 16, 41–48.PubMedCrossRefGoogle Scholar
  21. Cover, H. & Irwin, M. (1994). Immunity and depression: Insomnia, retardation, and reduction of natural killer cell activity. Journal of Behavioral Medicine, 17, 217–223.PubMedCrossRefGoogle Scholar
  22. Darko, D. F., Gillin, J. C., Risch, S. C., Bulloch, K., Golshan, S., Tasevska, Z., & Hamburger, R. N. (1989). Mitogen-stimulated lymphocyte proliferation and pituitary hormones in major depression. Biological Psychiatry, 26, 145–155.PubMedCrossRefGoogle Scholar
  23. Dietrich, J. B., Chasserot-Golaz, S., Beck, G., & Bauer, G. (1986). Antagonism of glucocorticoid induction of Epstein-Barr virus early antigens by different steriods in Daudi lymphoma cells. Journal of Steroid Biochemistry, 24, 417–421.PubMedCrossRefGoogle Scholar
  24. Dinges, D. F., Douglas, S. D., Zaugg, L., Campbell, D. E., McMann, J. M., Whitehouse, W. G., Orne, E. C., Kapoor, S. C., Icaza, E., & Orne, M. T. (1994). Leukocytosis and natural killer cell function parallel neurobehavioral fatigue induced by 64 hours of sleep deprivation. Journal of Clinical Investigation, 93, 1930–1939.PubMedGoogle Scholar
  25. Evans, D. L., Folds, J. D., Petitto, J. M., Golden, R. N., Pedersen, C. A., Corrigan, M., Gilmore, J. H., Silva, S. G., Quade, D., & Ozer, H. (1992). Circulating natural killer cell phenotypes in men and women with major depression. Archives of General Psychiatry, 49, 388–395.PubMedGoogle Scholar
  26. Ferson, I., Edwards, A., Lind, A., Milton, G. W., & Hersey, P. (1979). Low natural killer-cell activity and immunoglobulin levels associated with smoking in human subjects. British Journal of Cancer, 23, 603–609.Google Scholar
  27. Glaser, R., Kiecolt-Glaser, J. K., Bonneau, R. H., Malarkey, W., Kennedy, S., & Hughes, J. (1992). Stress-induced modulation of the immune response to recombinant hepatitis B vaccine. Psychosomatic Medicine, 54, 22–29.PubMedGoogle Scholar
  28. Hall, M., Baum, A., Buysse, D. J., Prigerson, H. G., Kupfer, D. J., & Reynolds, C. F. (1998). Sleep as a mediator of the stress-immune relationship. Psychosomatic Medicine, 60, 48–51.PubMedGoogle Scholar
  29. Hayward, A. R. & Herberger, M. (1987). Lymphocyte responses to varicella zoster virus in the elderly. Journal of Clinical Immunology, 7, 174–178.PubMedCrossRefGoogle Scholar
  30. Herbert, T. B. & Cohen, S. (1993a). Depression and immunity—A meta-analytic review. Psychological Bulletin, 113, 472–486.PubMedCrossRefGoogle Scholar
  31. Herbert, T. B. & Cohen, S. (1993b). Stress and immunity in humans: a meta-analytic review. Psychosomatic Medicine, 55, 364–379.PubMedGoogle Scholar
  32. Hickie, I., Hickie, C., Lloyd, A., Silove, D., & Wakefield, D. (1993). Impaired in vivo immune responses in patients with melancholia. British Journal of Psychiatry, 162, 651–657.PubMedGoogle Scholar
  33. Irwin, M. & Gillin, J. C. (1998). The neuroimmunology of normal and disturbed sleep. European Sleep Research Society, 1998, (abstract).Google Scholar
  34. Irwin, M., Smith, T. L., & Gillin, J. C. (1987). Low natural killer cytotoxicity in major depression. Life Sciences, 41, 2127–2133.PubMedCrossRefGoogle Scholar
  35. Irwin, M., Caldwell, C., Smith, T. L., Brown, S., Schuckit, M. A., & Gillin, J. C. (1990a). Major depressive disorder, alcoholism, and reduced natural killer cell cytotoxicity: Role of severity of depressive symptoms and alcohol consumption. Archives of General Psychiatry, 47, 713–719.PubMedGoogle Scholar
  36. Irwin, M. R., Patterson, T. L., Smith, T. L., Caldwell, C., Brown, S. A., Gillin, J. C., & Grant, I. (1990b). Reduction of immune function in life stress and depression. Biological Psychiatry, 27, 22–30.PubMedCrossRefGoogle Scholar
  37. Irwin, M., Lacher, U., & Caldwell, C. (1992a). Depression and reduced natural killer cytotoxicity: a longitudinal study of depressed patients and control subjects. Psychological Medicine, 22, 1045–1050.PubMedGoogle Scholar
  38. Irwin, M., Smith, T. L., & Gillin, J. C. (1992b). Electroencephalographic sleep and natural killer activity in depressed patients and control subjects. Psychosomatic Medicine, 54, 107–126.Google Scholar
  39. Irwin, M., Mascovich, A., Gillin, J. C., Willoughby, R., Pike, J., & Smith, T. L. (1994). Partial sleep deprivation reduces natural killer cell activity in humans. Psychosomatic Medicine, 56, 493–498.PubMedGoogle Scholar
  40. Irwin, M., McClintick, J., Costlow, C., Fortner, M., White, J., & Gillin, J. C. (1996). Partial night sleep deprivation reduces natural killer and cellular immune responses in humans. The FASEB Journal, 10, 643–653.PubMedGoogle Scholar
  41. Irwin, M., Costlow, C., Williams, H., Artin, K. H., Levin, M. J., Hayward, A. R., & Oxman, M. N. (1998). Cellular immunity to varicella-zoster virus in depression. Journal of Infectious Disease, in press.Google Scholar
  42. Jung, W. & Irwin, M. (1998). Reduction of natural killer cytotoxic activity in major depression. Submitted.Google Scholar
  43. Kiecolt-Glaser, J. K. & Glaser, R. (1995). Psychoneuroimmunology and health consequences: data and shared mechanisms. Psychosomatic Medicine, 57, 269–274.PubMedGoogle Scholar
  44. Kiecolt-Glaser, J. K., Glaser, R., Gravenstein, S., & Malarkey, W. B. (1996). Chronic stress alters the immune response to influenza virus vaccine in older adults. Proceedings of the National Academy of Sciences, 93, 3043–3047.CrossRefGoogle Scholar
  45. Kronfol, Z. & House, J. D. (1985). Depression, hypothalamic-pituitary adrenocortical activity, and lymphocyte function. Psychopharmacology Bulletin, 21, 476–478.PubMedGoogle Scholar
  46. Kronfol, Z. & House, J. D. (1989). Lymphocyte mitogenesis, immunoglobulin, and complement levels in depressed patients and normal controls. Acta Psychiatrica Scandinavica, 80, 142–147.PubMedCrossRefGoogle Scholar
  47. Kronfol, Z., House, J. D., Silva, J., Greden, J., & Carroll, B. J. (1986). Depression, urinary free cortisol excretion, and lymphocyte function. British Journal of Psychiatry, 148, 70–73.PubMedGoogle Scholar
  48. Kronfol, Z., Silva, J., Greden, J., Dembinski, S., Gardner, R., & Carroll, B. (1983). Impaired lymphocyte function in depressive illness. Life Sciences, 33, 241–247.PubMedCrossRefGoogle Scholar
  49. Kronfol, Z., Turner, R., Nasrallah, H., & Winokur, G. (1984). Leukocyte regulation in depression and schizophrenia. Psychiatry Research, 13, 13–18.PubMedCrossRefGoogle Scholar
  50. Kronfol, Z., Nair, M., Goodson, J., Goel, K., Haskett, R., & Schwartz, S. (1989). Natural killer cell activity in depressive illness: a preliminary report. Biological Psychiatry, 26, 753–756.PubMedCrossRefGoogle Scholar
  51. Kronfol, Z., Nair, M., Zhang, Q., Hill, E. E., & Brown, M. B. (1997). Circadian immune measures in healthy volunteers: relationship to hypothalamic-pituitary-adrenal axis hormones and sympathetic neurotransmitters. Psychosomatic Medicine, 59, 42–50.PubMedGoogle Scholar
  52. Linkins, R. W. & Comstock, G. W. (1990). Depressed mood and development of cancer. American Journal of Epidemiology, 132(5), 962–972.PubMedGoogle Scholar
  53. Lowy, M. T., Reder, A. T., Gormley, G. J., & Meltzer, H. Y. (1988). Comparison of in vivo and in vitro glucocorticoid sensitivity in depression: relationship to the dexamethasone suppression test. Biological Psychiatry, 24, 619–630.PubMedCrossRefGoogle Scholar
  54. Maes, M., Bosnians, E., Suy, E., Minner, B., & Raus, J. (1989). Impaired lymphocyte stimulation by mitogens in severely depressed patients. A complex interface with HPA-axis hyperfunction, noradrenergic activity, and the ageing process. British Journal of Psychiatry, 155, 793–798.PubMedGoogle Scholar
  55. Maes, M., Lambrechts, J., Bosmans, E., Jacobs, J., Suy, E., Vandervorst, C., deJonckheere, C., Minner, B., & Raus. J. (1992a). Evidence for a systemic immune activation during depression: results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining. Psychological Medicine, 22, 45–53.PubMedCrossRefGoogle Scholar
  56. Maes, M., Scharpe, S., Van Grootel, L., Uyttenbroeck, W., Cooreman, W., Cosyns, P., & Suy, E. (1992b). Higher alpha 1-antritrypsin, haptoglobin, ceruloplasmin, and lower retinol binding protein plasma levels during depression: further evidence for the existence of an inflammatory respose during that illness. Journal of Affective Disorders, 24, 183–192.PubMedCrossRefGoogle Scholar
  57. Maes, M., Stevens, W., Peeters, D., DeClerk, L., Scharpe, S., Bridts, C., Schotte, C., & Cosyns, P. (1992c). A study of the blunted natural killer cell activity in severely depressed patients. Life Science, 50, 505–513.CrossRefGoogle Scholar
  58. Maes, M., Smith, R., & Scharpe, S. (1995). The monocyte-T-lymphocyte hypothesis of major depression. Psychoneuroendocrinology, 20, 111–116.PubMedCrossRefGoogle Scholar
  59. Maier, S. F., Watkins, L. R., & Fleshner, M. (1994). Psychoneuroimmunology: the interface between behavior, brain, and immunity. American Journal of Psychology, 49, 1004–1017.CrossRefGoogle Scholar
  60. McAdams, C. & Leonard, B. E. (1993). Neutrophil and monocyte phagocytosis in depressed patients. Progess in Neuro-Psychopharmacology and Biological Psychiatry, 17, 971–984.CrossRefGoogle Scholar
  61. Meliska, C. J., Stunkard, M. E., Gilbert, D. G., Jensen, R. A., & Martinko, J. M. (1995). Immune function in cigarette smokers who quit smoking for 31 days. Journal of Allergy & Clinical Immunology, 95, 901–910.CrossRefGoogle Scholar
  62. Mendall, M. A., Patel, P., Asante, M., Ballam, L., Morris, J., Strachan, D. P., Camm, A. J., & Northfield, T. C. (1997). Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. Heart, 78, 273–277.PubMedGoogle Scholar
  63. Miller, A. H., Asnis, G. M., Lackner, C., Halbreich, U., & Norin, A. J. (1991). Depression, natural killer cell activity, and cortisol secretion. Biological Psychiatry, 29, 878–886.PubMedCrossRefGoogle Scholar
  64. Mohl, P. C., Huang, L., Bowden, C., Fischbach, M., Vogtsberer, K., & Talal, N. (1987). Natural killer cell activity in major depression (letter). American Journal of Psychiatry, 144, 1619PubMedGoogle Scholar
  65. Moldofsky, H., Lue, F. A., Davidson, J. R., & Gorczynski, R. (1989). Effects of sleep deprivation on human immune function. The FASEB Journal, 3, 1972–1977.PubMedGoogle Scholar
  66. Murphy, J. M., Oliver, D. C., Sobol, A. M., Monson, R. R., & Leighton, A. H. (1986). Diagnosis and outcome: depression and anxiety in a general population. Psychological Medicine, 16, 117–26.PubMedGoogle Scholar
  67. Nerozzi, D., Santoni, A., Bersani, G., Magnani, A., Bressan, A., Pasini, A., Antonozzi, I., & Frajese, G. (1989). Reduced natural killer cell activity in major depression: neuroendocrine implications. Psychoneuroendocrinology, 14, 295–302.PubMedCrossRefGoogle Scholar
  68. Oxman, M. N. & Alani, R. (1993). Varicella and Herpes Zoster. In T. B. Fitzpatrick & et al. (Eds.), Dermatology in General Medicine. (pp. 2543–2572). New York: McGraw-Hill Book Co.Google Scholar
  69. Palmblad, J., Petrini, B., Wasserman, J., & Akerstedt, T. (1979). Lymphocyte and granulocyte reactions during sleep deprivation. Psychosomatic Medicine, 41(4), 273–278.PubMedGoogle Scholar
  70. Parker, G., Hadzi-Pavlovic, D., Boyce, P., Wilhelm, K., Brodaty, H., Mitchell, P., Hickie, I., & Eyers, K. (1990). Classifying depression by mental state signs. British Journal of Psychiatry, 157, 55–65.PubMedCrossRefGoogle Scholar
  71. Petitto, J. M., Folds, J. D., Ozer, H., Quade, D., & Evans, D. L. (1992). Abnormal diurnal variation in circulating natural killer cell phenotypes and cytotoxic activity in major depression. American Journal of Psychiatry, 149, 694–696.PubMedGoogle Scholar
  72. Petitto, J. M., Folds, J. D., & Evans, D. L. (1993). Abnormal diurnal variation of B lymphocyte circulation patterns in Major Depression. Biological Psychiatry, 34, 268–267.PubMedCrossRefGoogle Scholar
  73. Petrovsky, N. & Harrison, L. C. (1997). Diurnal rhythmicity of human cytokine production. Journal of Immunology, 158, 5163–5168.Google Scholar
  74. Rapaport, M. H. & Irwin, M. (1996). Serum soluble interleukin-2 receptors and natural killer cell function in major depression. Communications in Biological Psychiatry, 21, 73–78.Google Scholar
  75. Schleifer, S. J., Keller, S. E., Meyerson, A. T., Raskin, M. J., Davis, K. L., & Stein, M. (1984). Lymphocyte function in major depressive disorder. Archives of General Psychiatry, 41, 484–486.PubMedGoogle Scholar
  76. Schleifer, S. J., Keller, S. E., Siris, S. G., Davis, K. L., & Stein, M. (1985). Depression and immunity: lymphocyte function in ambulatory depressed patients, hospitalized schizophrenic patients, and patients hospitalized for herniorrhaphy. Archives of General Psychiatry, 42, 129–133.PubMedGoogle Scholar
  77. Schleifer, S. J., Keller, S. E., Bond, R. N., Cohen, J., & Stein, M. (1989). Major depressive disorder and immunity: role of age, sex, severity, and hospitalization. Archives of General Psychiatry, 46, 81–87.PubMedGoogle Scholar
  78. Schuckit, M. A. (1986). Genetic and clinical implications of alcoholism and affective disorder. American Journal of Psychiatry, 143, 140–147.PubMedGoogle Scholar
  79. Sengar, D. P., Waters, B. G., Dunne, J. V., & Bover, I. M. (1982). Lymphocyte subpopulations and mitogenic responses of lymphocytes in manic-depressive disorders. Biological Psychiatry, 17, 1017–1022.PubMedGoogle Scholar
  80. Shain, B. N., Kronfol, Z., Naylor, M., Goel, K., Evans, T., & Schaefer, S. (1991). Natural killer cell activity in adolescents with major depression. Biological Psychiatry, 29, 481–484.PubMedCrossRefGoogle Scholar
  81. Sheridan, J. F., Dobbs, C., Brown, D., & Zwilling, B. (1994). Psychoneuroimmunology: stress effects on pathogenesis and immunity during infection. Clinical Microbiological Reviews 7, 200–212.Google Scholar
  82. Steiger, A. & Holsboer, F. (1997). Nocturnal secretion of prolactin and cortisol and the sleep EEG in patients with major endogenous depression during an acuted episode and after full remission. Psychiatry Research, 72, 81–88.PubMedCrossRefGoogle Scholar
  83. Stein, M. B. & Uhde, T. W. (1988). Panic disorder and major Depression. A tale of two syndromes. Psychiatry Clinics of North America, 11, 441–61.Google Scholar
  84. Stein, M., Miller, A. H., & Trestman, R. L. (1991). Depression, the immune system, and health and illness. Archives of General Psychiatry, 48, 171–177.PubMedGoogle Scholar
  85. Syvalahti, E., Eskola, J., Ruuskanen, O., & Laine, T. (1985). Nonsuppression of cortisol and immune function in depression. Proceedings in Neuropsychopharmacology & Biological Psychiatry, 9(4), 413–422.CrossRefGoogle Scholar
  86. Uthgenannt, D., Schoolmann, D., Pietrowsky, R., Fehm, H. L., & Born, J. (1995). Effects of sleep on the production of cytokines in humans. Psychosomatic Medicine, 57, 97–104.PubMedGoogle Scholar
  87. Weisse, C. S. (1992). Depression and immunocompetence: A review of the literature. Psychological Bulletin, 111(3), 475–489.PubMedCrossRefGoogle Scholar
  88. Zorilla, E. P., Luborsky, L., McKay, J. R., Rosenthal, R., Houldin, A., Tax, A., McCorkle, R., Seligman, D. A., & Schmidt, K. (1998). The relationship of depression and Stressors to immunological assays: a meta-analytic review. Brain, Behavior and Immunity, (in press).Google Scholar

Copyright information

© Kluwer Academic/Plenum Publishers 1999

Authors and Affiliations

  • Michael Irwin
    • 1
  1. 1.Departments of Psychiatry San Diego VA Medical CenterUniversity of CaliforniaSan Diego La Jolla

Personalised recommendations